June 21, 2004
Croda Expands Plant Capacity EAST YORKSHIRE, EnglandCroda Health Care has more than doubled its manufacturing capacity of omega-3 and omega-6 fatty acids by opening a new facility in Staffs, England. The new plant was built to pharmaceutical standards and employs advanced production technologies in its development of pharmaceutical-grade lipid concentrates. In North America, Croda products are exclusively distributed by Bioriginal Food & Science Corp., based in Saskatoon, Saskatchewan. Crodas increased expansion will allow us to offer even more of the highest-quality omega-3 oils to health and nutrition distributors across North America, said Joe Vidal, chief operating officer at Bioriginal (www.bioriginal.com). The recently approved health claim regarding omega-3s reducing the risk of cardiovascular disease has generated much media attention and created more consumer demand.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023